Literature DB >> 24528004

M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses.

Tristano Pancani1, Caroline Bolarinwa, Yoland Smith, Craig W Lindsley, P Jeffrey Conn, Zixiu Xiang.   

Abstract

The striatum is the main input station of the basal ganglia and is extensively involved in the modulation of motivated behavior. The information conveyed to this subcortical structure through glutamatergic projections from the cerebral cortex and thalamus is processed by the activity of several striatal neuromodulatory systems including the cholinergic system. Acetylcholine potently modulates glutamate signaling in the striatum via activation of muscarinic receptors (mAChRs). It is, however, unclear which mAChR subtype is responsible for this modulatory effect. Here, by using electrophysiological, optogenetic, and immunoelectron microscopic approaches in conjunction with a novel, highly selective M4 positive allosteric modulator VU0152100 (ML108) and M4 knockout mice, we show that M4 is a major mAChR subtype mediating the cholinergic inhibition of corticostriatal glutamatergic input on both striatonigral and striatopallidal medium spiny neurons (MSNs). This effect is due to activation of presynaptic M4 receptors, which, in turn, leads to a decrease in glutamate release from corticostriatal terminals. The findings of the present study raise the interesting possibility that M4 mAChR could be a novel therapeutic target for the treatment of neurological and neuropsychiatric disorders involving hyper-glutamatergic transmission at corticostriatal synapses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24528004      PMCID: PMC3990947          DOI: 10.1021/cn500003z

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  35 in total

1.  Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.

Authors:  Weilie Zhang; Masahisa Yamada; Jesus Gomeza; Anthony S Basile; Jürgen Wess
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

2.  Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain.

Authors:  S Sugita; N Uchimura; Z G Jiang; R A North
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen.

Authors:  Kalynda Kari Gonzales; Jean-Francois Pare; Thomas Wichmann; Yoland Smith
Journal:  J Comp Neurol       Date:  2013-08-01       Impact factor: 3.215

Review 4.  Functional roles of neurotransmitters and neuromodulators in the dorsal striatum.

Authors:  Jeehaeh Do; Jae-Ick Kim; Joseph Bakes; Kyungmin Lee; Bong-Kiun Kaang
Journal:  Learn Mem       Date:  2012-12-17       Impact factor: 2.460

5.  The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method.

Authors:  J M Kemp; T P Powell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1971-09-30       Impact factor: 6.237

6.  Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors.

Authors:  Eric Burguière; Patrícia Monteiro; Guoping Feng; Ann M Graybiel
Journal:  Science       Date:  2013-06-07       Impact factor: 47.728

7.  Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro.

Authors:  R C Malenka; J D Kocsis
Journal:  J Neurosci       Date:  1988-10       Impact factor: 6.167

8.  M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.

Authors:  Eleni T Tzavara; Frank P Bymaster; Richard J Davis; Mark R Wade; Kenneth W Perry; Jurgen Wess; David L McKinzie; Chris Felder; George G Nomikos
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

9.  Targeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.

Authors:  James C Tarr; Mark L Turlington; Paul R Reid; Thomas J Utley; Douglas J Sheffler; Hyekyung P Cho; Rebecca Klar; Tristano Pancani; Michael T Klein; Thomas M Bridges; Ryan D Morrison; Anna L Blobaum; Zixui Xiang; J Scott Daniels; Colleen M Niswender; P Jeffrey Conn; Michael R Wood; Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-07-18       Impact factor: 4.418

10.  Acetylcholine encodes long-lasting presynaptic plasticity at glutamatergic synapses in the dorsal striatum after repeated amphetamine exposure.

Authors:  Wengang Wang; Martin Darvas; Granville P Storey; Ian J Bamford; Jeffrey T Gibbs; Richard D Palmiter; Nigel S Bamford
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

View more
  38 in total

1.  High-Frequency Activation of Nucleus Accumbens D1-MSNs Drives Excitatory Potentiation on D2-MSNs.

Authors:  T Chase Francis; Hideaki Yano; Tyler G Demarest; Hui Shen; Antonello Bonci
Journal:  Neuron       Date:  2019-06-17       Impact factor: 17.173

Review 2.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

3.  Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus.

Authors:  Rebecca Klar; Adam G Walker; Dipanwita Ghose; Brad A Grueter; Darren W Engers; Corey R Hopkins; Craig W Lindsley; Zixiu Xiang; P Jeffrey Conn; Colleen M Niswender
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

4.  M1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons.

Authors:  Xiaohui Lv; Jonathan W Dickerson; Jerri M Rook; Craig W Lindsley; P Jeffrey Conn; Zixiu Xiang
Journal:  Neuropharmacology       Date:  2017-03-20       Impact factor: 5.250

5.  African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction.

Authors:  Orna Levran; Matthew Randesi; Einat Peles; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2016-06-07       Impact factor: 2.533

Review 6.  Physiological roles of CNS muscarinic receptors gained from knockout mice.

Authors:  Morgane Thomsen; Gunnar Sørensen; Ditte Dencker
Journal:  Neuropharmacology       Date:  2017-09-11       Impact factor: 5.250

Review 7.  Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

Authors:  Daniel J Foster; P Jeffrey Conn
Journal:  Neuron       Date:  2017-05-03       Impact factor: 17.173

8.  Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition.

Authors:  Michael R Wood; Meredith J Noetzel; James C Tarr; Alice L Rodriguez; Atin Lamsal; Sichen Chang; Jarrett J Foster; Emery Smith; Peter Chase; Peter S Hodder; Darren W Engers; Colleen M Niswender; Nicholas J Brandon; Michael W Wood; Mark E Duggan; P Jeffrey Conn; Thomas M Bridges; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2016-07-21       Impact factor: 2.823

9.  M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.

Authors:  Weixing Shen; Joshua L Plotkin; Veronica Francardo; Wai Kin D Ko; Zhong Xie; Qin Li; Tim Fieblinger; Jürgen Wess; Richard R Neubig; Craig W Lindsley; P Jeffrey Conn; Paul Greengard; Erwan Bezard; M Angela Cenci; D James Surmeier
Journal:  Neuron       Date:  2015-11-18       Impact factor: 17.173

Review 10.  The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis.

Authors:  M D Scofield; J A Heinsbroek; C D Gipson; Y M Kupchik; S Spencer; A C W Smith; D Roberts-Wolfe; P W Kalivas
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.